Controlled attenuation parameter-measured hepatic steatosis independently predicts greater coronary artery disease complexity in patients with AMI. Patients with acute myocardial infarction (AMI) and ...

Patients using GLP-1 RAs may experience dermatologic adverse side effects, including skin laxity, hair shedding, and facial ...

Twenty-four weeks of bepirovirsen achieves a functional cure in approximately one-fifth of patients with chronic hepatitis B.

Daraxonrasib significantly prolonged survival in previously treated mPDAC, supporting its use as a new treatment option for patients with RAS-driven disease. Daraxonrasib prolongs overall and ...

There was a significant inflection in call volume, with semaglutide exposures increasing an additional 9.9% per quarter after FDA approval. (HealthDay News) — Glucagon-like peptide-1 receptor agonist ...

Anti-TNF therapy has the most favorable safety and disease-control profile during pregnancy, with vedolizumab and ustekinumab performing similarly.

Upadacitinib and infliximab provide the most rapid onset of symptom improvement among those with moderate to severe UC with no medical history of biologic therapy. Upadacitinib and infliximab have the ...

Same-day administration of COVID-19 and influenza vaccines is not associated with increased risk for adverse events.

While the role of the gut-joint axis has been recognized in SpA, evidence shows diet should be used as an adjunct to ...

Inviting patients to undergo combined Helicobacter pylori stool antigen testing with fecal immunochemical testing (FIT) yielded superior cost-effectiveness compared with FIT alone ...

Poor nocturnal sleep is independently associated with a substantially higher risk for MASLD in adults with type 2 diabetes.